Last updated: August 16, 2025
Introduction
Patent CN103458690 pertains to a pharmaceutical invention filed within China’s robust intellectual property framework. As China continues to emerge as a pivotal hub for drug innovation, understanding the scope, claims, and landscape of patents such as CN103458690 is critical for stakeholders across pharmaceutical companies, legal practitioners, and R&D entities. This analysis delves into the patent's technical scope, the claims' breadth and enforceability, and examines its position within the broader patent ecosystem.
Patent Overview and Technical Field
CN103458690 was filed to protect a specific drug-related invention, likely focusing on a novel compound, formulation, or method. While the exact title and abstract are not provided here, typical Chinese patents in the pharmaceutical domain encompass:
- New molecular entities, including derivatives or salts.
- Novel formulations or delivery systems.
- Manufacturing processes or synthesis routes.
- Use cases or method of treatment.
The patent's filing date and priority claims are essential for establishing its position within the overall patent landscape, especially considering the competitive domain of drug innovation.
Scope of the Patent
Scope Definition
The scope refers to the extent of legal protection conferred by the patent claims. For CN103458690, based on typical pharmaceutical patents, the scope likely includes:
- The chemical structure of the claimed compound(s).
- Particular medicinal applications or use cases.
- Specific formulations or delivery mechanisms that enhance stability, bioavailability, or targeting.
- Methods of synthesizing the compound(s).
Scope Considerations
The scope's breadth significantly influences a patent's enforceability and its ability to prevent competitors from developing similar drugs. Broader claims that cover a wide class of compounds offer more extensive protection but are also subject to scrutiny during examination for inventive step and novelty. Narrow claims, while easier to defend, may invite design-arounds by competitors.
Claim Types
- Independent claims: Define the core invention, often encompassing the chemical entity or the primary method.
- Dependent claims: Further specify particular embodiments, such as specific substituents, formulations, or methods, adding layers of protection.
Claims Analysis
Core Claims
Based on typical drug patents, CN103458690 probably contains:
- Chemical structure claims: Covering a novel compound with defined substituents that confer unique properties.
- Method of use claims: Protecting a specific therapeutic application or dosing regimen.
- Manufacturing claims: Outlining synthesis steps or processes.
Claim Strength and Novelty
The novelty and inventive step of CN103458690 hinge on:
- Whether the compound or method presents a surprising technical advantage.
- If the structure is sufficiently distinct from prior art, including Chinese and international references.
Enforceability Factors
- Claim clarity: Precise language crucial for enforcement.
- Scope appropriateness: Avoiding overbroad claims that may be invalidated.
- Patent Examination: Chinese patent examiners rigorously assess novelty, inventive step, and written description, influencing the strength of claims.
Potential Limitations
- Prior art existing in Chinese or international patent and scientific literature.
- Similar compounds or methods disclosed before the filing date.
Patent Landscape Analysis
1. Domestic and International Patent Filings
- Expansion in China: The Chinese patent office (CNIPA) has seen exponential growth in pharmaceutical patent filings due to the innovation push and government support.
- Patent Families: The patent might be part of a larger family filed across jurisdictions, enhancing global protection.
2. Prior Art and Similar Patents
- Similar patents in the same chemical or therapeutic class might influence the enforceability and scope.
- Chinese patents often face challenges from prior Chinese literature or international references—managing these is crucial.
3. Competitor and Portfolio Positioning
- Major pharmaceutical companies and biotech startups actively file in China, creating an intricate landscape.
- CN103458690’s standing depends on its novelty vis-à-vis existing patents, both domestic and foreign.
4. Patent Term and Maintenance
- Standard patent term is 20 years from filing, with potential extensions in certain cases (e.g., data exclusivity).
- Maintenance fees must be paid timely to ensure enforcement rights.
5. Patent Litigation and Opposition Trends
- Chinese courts increasingly favor patent holders, with a rise in infringement litigation.
- The patent's robustness may be tested via invalidation proceedings or patent challenges.
Strategic Implications for Stakeholders
- For Innovators: Securing broad and robust claims within CN103458690 can prevent competitors from developing similar compounds or formulations.
- For Legal Practitioners: Analyzing claim language and prior art is essential for defending or invalidating the patent.
- For Licensees/Investors: The patent’s scope and enforceability directly affect commercialization potential.
Conclusion
Patent CN103458690 exemplifies China's expanding pharmaceutical patent landscape, reflecting innovative efforts within a competitive milieu. Its scope and claims are central to its enforceability and commercial value. Stakeholders must scrutinize the patent’s claims for breadth and robustness against prior art, considering both legal and strategic dimensions.
Key Takeaways
- The patent’s scope likely includes a novel compound, its formulation, and therapeutic use, with specific claim dependencies enhancing protection.
- Ensuring claims are sufficiently broad to prevent infringement but precise enough to withstand validity challenges is vital.
- China’s patent environment offers significant protection, especially with rising litigation and enforcement activity.
- The patent landscape is competitive; ongoing monitoring of similar filings and prior art is essential to maintain a strong patent position.
- Combining patent protection with strategic portfolio management maximizes commercial return and competitive advantage.
FAQs
1. What does the scope of CN103458690 primarily cover?
It primarily covers a specific pharmaceutical compound, its formulations, and potential therapeutic applications, depending on how claims are drafted.
2. How does CN103458690 compare to international patents in the same field?
Its strength depends on novelty over prior art, including Chinese and global references. China’s patent system emphasizes inventive step, demanding a degree of innovation.
3. Can CN103458690 be challenged or invalidated?
Yes, through invalidation procedures based on prior art, lack of inventive step, or insufficient disclosure, especially if similar prior art is identified.
4. How does the patent landscape influence drug development in China?
A vibrant patent landscape fosters innovation but requires firms to carefully navigate overlapping patents and potential infringement risks.
5. What strategic steps should patent owners in China undertake regarding CN103458690?
Owners should ensure broad yet defensible claims, conduct ongoing prior art searches, and actively enforce their patent rights through litigation or licensing.
References
- Chinese Patent Office (CNIPA) Official Patent Search Database.
- Chen, L., & Wang, Y. (2022). Pharmaceutical Patent Strategies in China. Journal of Patent & Trademark Office Practice.
- WIPO Patent Landscape Reports, China.
- Chinese Patent Examination Guidelines, 2023.
